Cargando…
Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
INTRODUCTION: Breast cancer is a common disease with distinct tumor subtypes phenotypically characterized by ER and HER2/neu receptor status. MiRNAs play regulatory roles in tumor initiation and progression, and altered miRNA expression has been demonstrated in a variety of cancer states presenting...
Autores principales: | McDermott, Ailbhe M., Miller, Nicola, Wall, Deirdre, Martyn, Lorcan M., Ball, Graham, Sweeney, Karl J., Kerin, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909065/ https://www.ncbi.nlm.nih.gov/pubmed/24498016 http://dx.doi.org/10.1371/journal.pone.0087032 |
Ejemplares similares
-
Identification and Validation of miRNAs as Endogenous Controls for RQ-PCR in Blood Specimens for Breast Cancer Studies
por: McDermott, Ailbhe M., et al.
Publicado: (2013) -
Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer
por: Waters, Peadar S., et al.
Publicado: (2012) -
Luminal DMSO: Effects on Detrusor and Urothelial/Lamina Propria Function
por: Smith, Katrina J., et al.
Publicado: (2014) -
Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
por: Davey, Matthew G., et al.
Publicado: (2023) -
Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland
por: Veryaskina, Yuliya A., et al.
Publicado: (2020)